robert rifkin, md, facp, tells us about the outcomes of the lyra study presented at ash 2019
Published 4 years ago • 4 plays • Length 0:50
Download video MP4
Download video MP3
Similar videos
-
1:09
robert rifkin, md, discusses the outcomes of the tourmaline-mm3 study
-
1:03
robert rifkin, md, talks about what clinical data could change the way multiple myeloma is treated
-
1:41
robert m. rifkin, md, facp, speculates on the promise of bispecific antibodies in mm
-
1:15
robert m. rifkin, md, facp, considers progression-free survival in mm when treating with isatuximab
-
1:17
robert rifkin, md, discusses the rationale for genetically profiling aml patients
-
1:20
robert rifkin, md, shares his thoughts on if a rituximab biosimilar can replace rituximab
-
0:47
robert rifkin, md, explains whether or not anti-bcma car-t cell therapy looks promising
-
1:27
robert kruse, md, phd
-
3:25
brain tumor | northwestern medicine
-
32:11
barbara dutrow (keynote): “tourmaline and geologic evolution”
-
7:56
sulpizio cardiovascular center: celebrating 10 years of world-class care
-
1:01
unlock kidney power
-
1:47
scott a. resnick, md
-
1:29
meet dr. robert sokolic
-
1:55
robert kirsner md phd
-
1:01
anti-cancer force of the microbiome, immune-boosting rapamycin, chemo-kinesiology | trailer
-
2:46
robert klecz, md - physiatrist - memorial rehabilitation institute
-
2:57
robert s. feder, md
-
0:34
huang et al, winner 2016 eureka prize for innovation in medical research
-
0:51
find the right heart doctor
-
3:18
04-16-2015, "retiring boomers: benefit or burden?" by richard p. holm, md
-
13:44
medphys - 18.1 - qa: principles of qa.
Clip.africa.com - Privacy-policy